Research Notes

Same Enzyme Repairs DNA, Repels Pathogens An enzyme involved in genome defense has been shown to attack invading pathogens (W-M. Chu et al., "DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA," Cell, 103:909-18, Dec. 8, 2000). Researchers already knew that DNA-dependent protein kinase (DNA-PK) in the nucleus repairs DNA double-stranded breaks created by radiation, but the role of DNA-PK in the cytoplasm was unknown. Testing DNA immunostimulatory (ISS) sequences in

Written byJennifer Fisher Wilson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

An enzyme involved in genome defense has been shown to attack invading pathogens (W-M. Chu et al., "DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA," Cell, 103:909-18, Dec. 8, 2000). Researchers already knew that DNA-dependent protein kinase (DNA-PK) in the nucleus repairs DNA double-stranded breaks created by radiation, but the role of DNA-PK in the cytoplasm was unknown. Testing DNA immunostimulatory (ISS) sequences in mice bred without DNA-PK, scientists at University of California, San Diego, discovered that the enzyme is the key to activating transcription factor NF-*B, leading to the activation of pathogen-attacking macrophages. Mice bred without the DNA-PK failed to mount an immune response against bacteria, viruses, and toxins. The scientists had theorized that the human body's innate immunity, the body's first-line defense system, must react like lower organisms such as bacteria to invading pathogens. But humans don't have restrictive enzymes like bacteria. "So we looked ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies